Medicine and Dentistry
Therapeutic Procedure
100%
Serum
100%
Marker
100%
Nasopharynx Carcinoma
100%
Synapsin II
100%
Macrophage Inflammatory Protein
100%
Patient
69%
Epstein-Barr Virus
38%
Carcinoma Cell
30%
DNA
30%
Biological Marker
15%
Disease
15%
Assay
15%
Immunoglobulin A
15%
Virus Capsid Antigen
15%
Cells
7%
Tissues
7%
Measurement
7%
Enzyme Linked Immunosorbent Assay
7%
Cell Function
7%
Multivariate Analysis
7%
Overall Survival
7%
Prognosis
7%
Plasma
7%
Tumor Cell
7%
Association
7%
Metastatic Carcinoma
7%
Immunohistochemistry
7%
Spontaneous Remission
7%
Population Research
7%
Neoplasm
7%
Immunofluorescence Test
7%
Cell Motility
7%
Univariate Analysis
7%
Distant Metastasis
7%
Distant Metastasis Free Survival
7%
Pharmacology, Toxicology and Pharmaceutical Science
Nasopharynx Carcinoma
100%
Macrophage Inflammatory Protein
100%
Synapsin II
100%
DNA
30%
Diseases
15%
Neoplasm
15%
Biological Marker
15%
Immunoglobulin A
15%
Virus Capsid Antigen
15%
RNA
7%
Metastasis
7%
Overall Survival
7%
Enzyme-Linked Immunosorbent Assay
7%
Prognosis
7%
Distant Metastasis
7%
Remission
7%
Population Study
7%
Distant Metastasis Free Survival
7%
Immunology and Microbiology
Macrophage Inflammatory Protein
100%
Epstein Barr Virus
38%
Carcinoma Cell
30%
Immunoglobulin A
15%
Virus Capsid Antigen
15%
Cells
7%
Association
7%
Blood Level
7%
Tissues
7%
ELISA
7%
Sample
7%
Cell Function
7%
Overall Survival
7%
Cell Motility
7%
Blood Plasma
7%
Tumor Cell
7%
RNA Interference
7%
Real-Time Polymerase Chain Reaction
7%
Immunofluorescence
7%
Distant Metastasis Free Survival
7%
Population Research
7%